|
5-azacytidine Clinical Trials
3 actively recruiting trials across 3 locations
▲ +1 trial since May 2026
Also known as: Vidaza, azacytidine
Pipeline
Early 1: 1Phase 1: 1Phase 2: 1
Top Sponsors
- Mohammed Milhem1
- Benjamin Tomlinson1
- Barbara Burtness1
Indications
- Cancer3
- MDS/MPN Crossover Syndromes1
- Metastatic Tumor1
- Locally Advanced Solid Tumor1
- Squamous Cell Carcinoma of Head and Neck1
New Haven, Connecticut1 trial
Phase 2
Iowa City, Iowa1 trial
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
University of Iowa Health Care
Phase 1
Cleveland, Ohio1 trial
5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.